RGRegina Célia Teixeira Gomes

Regina Célia Teixeira Gomes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Regina Célia Teixeira Gomes has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Ricardo Santos Simões

    Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 17012-901, SP, Brazil

    10 shared publications
  • José Maria Soares Júnior

    Laboratório de Ginecologia Estrutural e Molecular (LIM-58), Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas HC-FMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05403-010, Brazil

    7 shared publications
  • Manuel de Jesus Simões

    Universidade de São Paulo

    7 shared publications
  • Edmund C. Baracat

    Faculty of Medicine University of São Paulo, Obstetrics and Gynecology Department, FMUSP, Brazil; Obstetrics and Gynecology Department, Federal University of São Paulo, UNIFESP, Brazil

    5 shared publications
  • Helena Bonciani Nader

    Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, Brazil

    5 shared publications
  • Edmund Chada Baracat

    Laboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil

    4 shared publications

Latest Publications

  • Open Access

    Metoclopramide-induced hyperprolactinemia during pregnancy and lactating alters chondrocyte proliferation and apoptosis in the murine femoral and tibial epiphyseal growth plate

    by Osvaldo P. Araujo-Jr, Regina C.T. Gomes, Ariadne S.L. Araujo, Edmund C. Baracat, Ricardo S. Simões, Manuel de J. Simões, José M. Soares Junior

  • Hyperprolactinemia modifies extracellular matrix components associated with collagen fibrillogenesis in harderian glands of non- and pregnant female mice

    by Ariadne S.L. Araujo, Manuel de J. Simões, Osvaldo P. Araujo-Jr, Ricardo S. Simões, Edmund C. Baracat, Helena B. Nader, José M. Soares-Jr, Regina C.T. Gomes


  • Hyaluronic acid and proliferation/cellular death amount in the female rats mammary gland after estroprogestative therapy

    by Sueli M. P. S. Torres, Helena B. Nader, Ricardo S. Simões, Edmund C. Baracat, José M. Soares-Jr, Manuel de J. Simões, Regina C. T. Gomes

    To evaluate the concentration of hyaluronan acid and proliferation/cellular death in mammary gland of ovariectomized female rat after estroprogestative therapy. Forty ovariectomized female rats were divided into four groups with 10 animals/each: OG (vehicle); EG: (Estradiol, 7 days of treatment), PG (Progesterone acetate, 23 days of treatment), and EPG: (Estradiol, 7 days of treatment, and next Progesterone acetate, 23 days of treatment). Twenty-four hours after the last treatment, all animals were euthanized, the mammary gland removed, then, a fragment was immersed in acetone to quantifying of the hyaluronan acid biochemical method (ELISA-Like fluorometric assay), and a fragment fixed for 24 h in 10% formaldehyde in phosphate-buffered saline (PBS) processed for immunohistochemistry method for detection of the cell marker proliferation (Ki67) and cellular marker death by DNA fragmentation the TUNEL method. The estradiol-treatment alone (EG) or associated with progesterone (EPG) affected the concentration of hyaluronan acid, increased cell proliferation, and decreased cell death compared to OG and PG (p < .05) in the mammary tissue. Our results suggest that the excessive reduction of HA in mammary tissue, as occurred with progesterone treatment, can lead to a breakdown of the extracellular matrix. These changes may be indicative of mammary pathology such as the development of tumor.


  • Open Access

    Imbalance between the cellular proliferation and death in harderian gland of female mice with hyperprolactinemia

    by Ariadne Stavare Leal Araújo, Carina Verna, Osvaldo Pereira Araújo Júnior, José Maria Soares Júnior, Ricardo Santos Simões, Edmund Chada Baracat, Manuel de Jesus Simões, Regina Célia Teixeira Gomes

    OBJECTIVE: To assess the impact of the metoclopramide-induced hyperprolactinemia in cellular death and proliferation in the harderian gland of female mice. METHODS: Twenty female mice were divided into two groups of 10 animals each and treated: 0.2 mL of saline solution (controls, Ctr) and 200 mu g of metoclopramide (experimental, hyperprolactinemia), both for 50 consecutive days and at 12:00 a.m. On the 50th day, the female were euthanized, and the harderian glands were removed and processed for immunohistochemistry for detected ki67 and TUNEL method. Data were statistically analyzed by unpaired Student's t test (p<0.05). RESULTS: The harderian gland of the hyperprolactinemia group showed increase in the immunoexpression of Ki67 and TUNEL compared to the Ctr group (p<0.05), and there was no significant difference in the amount of porphyrin in the HPrl group compared to the Ctr group. CONCLUSION: The hyperprolactinemia led to increased cell death in the acini the harderian gland and cell proliferation in the stroma glandular, fact that suggesting a reduction process of cellular activity and fibrosis, which suggests impairment in the functioning of the lacrimal harderian.

  • Open Access

    Personalized functional gynecology: a new direction?

    by Dirceu Henrique Mendes Pereira, Silvana Chedid Grieco, Symara De Angelis Trivellato, Simone Nahas, Regina Teixeira Teixeira Gomes, Alexandre de Luca, José Maria Soares Júnior, Edmund Chada Baracat

    CNCDs are cutting our existence short, destroying our quality of life, burdening the government budget, and threatening the health of future generations. Unfortunately, conventional medicine has failed in responding to this challenge, and, as a result, the prevalence of chronic diseases continues to rise.

  • The molecular effects of electrical stimulation on the muscle components of the urethra of female rats after trauma by vaginal distention

    by Gisela R. F. Salerno, Maria A. T. Bortolini, Regina C. T. Gomes, Suellen M. Feitosa, Manuel J. Simões, Edmar Zanoteli, Fernanda L. Castanho, Rodrigo A. Castro

    Aims: To evaluate the expression of genes and proteins related to the urethral muscles of female rats after trauma by vaginal distention (VD) and after electrical stimulation therapy (EST).Methods: We compared the urethras of four groups of 20 animals each: control without trauma (C), 7 (recent‐trauma) and 30 days (late‐trauma) post‐VD, and VD‐treated with EST. We evaluated the expression of myogenic regulatory factors MYOD1 and myogenin (MYOG); skeletal muscle myosin heavy chain 1, 2, and 3 (MYH1, MYH2, and MYH3); smooth muscle MYH11; and myosin light chain 9 (MYL9). We used real‐time quantitative polymerase chain reaction, Western blot analysis, and immunohistochemistry.Results: MYOD1 and MYOG genes were overexpressed in the recent‐trauma group compared with the other groups (P < .05). MYH1 and MYH3 genes were upregulated in the recent‐trauma group compared with the control and EST groups (P < .05). The MYH2 gene was overexpressed in the late‐trauma group (P < .05), while the MYH2 protein was significantly increased in the EST group compared with control, recent‐trauma and late‐trauma groups by 5‐, 3‐, and 2.7‐fold change, respectively (P < .05). MYL9 and MYH11 messenger RNA were overexpressed in both trauma groups compared with control and EST groups (P < .05). MYH11 protein was not different among the study groups (P > .05).Conclusions: EST enhances the recovery of the damaged urethral tissue of rats mainly by acting on the striated‐muscle components. The MYH2 pathway underlies the positive effects of EST in the external urethral sphincter.


  • Concentration of sulfated glycosaminoglycans in the mammary tissue of female rats with the aging and about hormonal influence

    by Sueli M. P. S. Torres, Helena B. Nader, Ricardo S. Simões, Edmund C. Baracat, Manuel de J. Simões, Luiz F. P. Fuchs, José Maria Soares-Jr, Regina Célia T. Gomes

    It was to evaluate the concentration of sulfate glycosaminoglycans (GAG) in mammary tissue of the young and adult female rats and ovariectomized females rats after hormonal stimulation. For this purpose, 60 female rats were divided into six groups with 10 animals/each: nonovariectomized groups: G1 (5 months), and G2 (15 months) and ovariectomized groups: OG (vehicle); EG: (estradiol, 7 days of treatment), PG (progesterone acetate, 23 days of treatment) and EPG: (estradiol (7 days of treatment) and next progesterone acetate (23 days of treatment). Twenty-four hours after the last treatment, all animals were euthanized, the mammary tissue removed, processed for biochemical evaluation and quantification of the GAG. The comparison between groups showed that the concentration dermatan sulfate (DS) G1 was lower compared to G2, OG, EG (p < .05) and G2 was lower compared to OG (p < .05), and OG was higher compared to EG, GP, EPG (p < .05); and heparan sulfate (HS) G1 was higher compared to G2 (p < .05), and G2 was higher compared to OG, EP, PG and EPG (p < .05). These changes in the extracellular matrix might explain, at least in part, hormonal influence about sulfated glycosaminoglycans in response to physiological state/age, and in response to hormonal treatment in the mammary tissues.


  • Concentration of glycosaminoglycan in ovariectomized mice uterus after treatment with ovarian steroids

    by Gabriela C. C. C. Maioral, Regina Célia T. Gomes, Carina Verna, Manuel de J. Simões, Helena B. Nader, Ricardo S. Simões, Edmund C. Baracat, José Maria Soares-Jr

    The aim of this study was to evaluate the amount of non- and sulfated glycosaminoglycans in the ovariectomized mice uterus, after treatment with ovarian steroids. For this purpose, 50 adult female mice were divided into five groups with 10 animals/each: control group: CG (ovary intact), and ovariectomized groups: OG (vehicle), EG (estradiol), PG (progesterone) and EPG (estradiol combined to progesterone). The treatments started 30 days after ovariectomy. All the animals were treated for 50 consecutive days. These hormones were administered in a sterile oily solution via gavage. Twenty-four hours after the last treatment, all animals were euthanized, removing the uterine horn for biochemical analyses. To quantify, the hyaluronic acid (HA) used ELISA-like fluorometric assay, and the sulfated glycosaminoglycans (GAGs) used agarose gel electrophoresis. The amount of HA was significantly higher in the group treated with progesterone (PG) compared to the others groups (p < 0.05), and in the group treated with estradiol (EG), the amount of chondroitin/dermatan sulfate was significantly higher compared to the others groups (p < 0.05), and in the group treated with progesterone (PG), the amount of heparan sulfate was significantly lower compared to the others groups, except to control group (p < 0.05). Our results showed that the estroprogestative therapy after long time (50 days) profoundly affected the amount of glycosaminoglycans in uterine. These changes may be indicative of uterine pathology such as the development of tumor.


  • Open Access

    Influence of hyperprolactinemia on collagen fibers in the lacrimal gland of female mice

    by Ariadne Stavare Leal Araujo, Manuel de Jesus Simões, Carina Verna, Ricardo Santos Simões, José Maria Soares Júnior, Edmund Chada Baracat, Regina Célia Teixeira Gomes

    To quantify the collagen fibers in the lacrimal gland of female mice with hyperprolactinemia. Forty adult female mice were randomly divided into two groups with 20 animals each: nonpregnant control (CTR1, control group, 0.2 mL of saline solution) and nonpregnant experimental (HPRL1, experimental group, 200 µg/day metoclopramide). Treatments lasted for 50 consecutive days. On day 50, 10 females from each group (control and experimental) were euthanized in the proestrus phase; then, the blood was collected and the lacrimal glands were removed. Thereafter, the remaining females were placed with the mates and continued to receive treatment with saline solution or metoclopramide. On the 6th post-coital day, 10 pregnant females from the control group (CTR2) and 10 pregnant females from the experimental group (HPRL2) were euthanized, after which blood was collected and the lacrimal glands removed. The lacrimal glands were processed for morphological analyses and collagen quantification, and prolactin and sex steroid levels were measured in the blood samples. Data were statistically analyzed using an unpaired Student t test (p<0.05). Morphological analysis revealed greater structural tissue disorganization of the lacrimal glands in the metoclopramide-treated groups. The total collagen content was significantly higher in the HPRL1 group than in the CTR1 group (p<0.05), whereas the difference between the CTR2 and HPRL2 groups was not significant. Our data suggest an impairment in the functioning of the lacrimal gland as a consequence of increased prolactin levels and decreased serum levels of estrogen and progesterone.


  • Effects of hyperprolactinemia on the tibial epiphyseal plate of mice treated with sex hormones

    by Roberta B. Wolff, Regina Celia T. Gomes, Vinicius C. Do Amaral, Priscilla L. da Silva, Tommaso Simoncini, Fabio Cesar Prosdocimi, Ricardo S. Simoes, Manuel Jesus S. Simões, Edmund C. Baracat, José Maria Soares-Jr

    The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the tibial epiphyseal plate of hormone-treated oophorectomized mice. For this purpose, 18 animals with intact ovaries were allocated to two groups, M (metoclopramide) and V (vehicle). One hundred and eight oophorectomized animals were allocated to 12 subgroups: Oophx/V (vehicle); Ooph/M (metoclopramide); Oophx/V + E (vehicle + estradiol); Oophx/M + E (metoclopramide + estradiol); Oophx/V + P (vehicle + progesterone); Oophx/M + P (metoclopramide + progesterone); Oophx/V + T (vehicle + testosterone); Oophx/M + T (metoclopramide + testosterone); Oophx/V + E + P (Vehicle + estradiol + progesterone); Oophx/M + E + P (metoclopramide + estradiol + progesterone); Oophx/V + E + P + T (vehicle + estradiol + progesterone + testosterone); Oophx/M + E + P + T (metoclopramide + estradiol + progesterone + testosterone). After a 50-day treatment was performed histomorphometric and immunohistochemical cell death analysis. In the epiphyseal plate of the hyperprolactinemic and/or oophorectomized animals, cell proliferation and bone formation decreased, inducing intensified cell death. In the sex steroid-treated animals, estrogen boosted cell proliferation; progesterone, bone formation and testosterone, both cell proliferation and bone formation. These findings suggest that oophorectomy and hyperprolactinemia changed epiphyseal plate morphology causing cartilage degeneration. Treatment with combined sex steroids may diminish such deleterious effects.